Gilead is making headlines with its planned acquisition of Tubulis GmbH, a Germany-based company, for a maximum of five billion dollars. Th...

Local drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...

Biocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...

Shares of Kodiak Sciences surged 68.6% to their highest in more than four years on Thursday after the drug developer's experimental drug me...

New data from Europe's biggest oncology meeting reveals a high-stakes race for patients with a tough breast cancer. Astra and Daiichi's Dat...

AstraZeneca Pharma has secured approval from India's drug regulator for its cancer treatment Trastuzumab Deruxtecan. This drug is now appro...

Piramal Healthcare prioritizes organic growth for the next 4-5 years. The company will explore licensing and product acquisitions in comple...

Enhertu, a collaboration between AstraZeneca and Daiichi Sankyo, gains FDA approval for treating HER2-positive solid tumors spread througho...

British-Swedish drugmaker AstraZeneca is set to launch 15 new products in India from 2023 to 2025, focusing on oncology, cardiovascular, re...

Biologics capabilities can be synergistic with the company's anti-body drug conjugation capabilities; specifically, for customers who prefe...

“This is an important milestone for SPARC. The licensing of antibodies from Biomodifying will assist us in our endeavour to transition SPAR...

Consolidated total revenue from operations stood at Rs 4,025.4 crore for the quarter under consideration against Rs 3,514.6 crore for the s...

"In a step that can significantly reduce treatment cost by almost 80 per cent, the drug is being offered at Rs 32,495 for a 100 mg vial. Th...

The new facility is expected to create up to 20 new high-skill job roles, backed by £200,000 Regional Selective Assistance funding.

Mumbai-based Piramal Healthcare has teamed up with Japan's Fujifilm Diosynth for a contract manufacturing deal that would look to develop a...

Piramal Enterprises today said its healthcare vertical has tied up with Fujifilm Diosynth Biotechnologies for co-operation in biopharmaceut...

Biotech major Biocon Ltd on Thursday said it will enter into a partnership with a US-based biotechnology company, Iatrica, to develop drug ...